GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
96 hedge funds and large institutions have $51.5M invested in G1 Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 37 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
62% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 29
Holders
96
Holding in Top 10
–
Calls
$431K
Puts
$121K
Top Buyers
| 1 | +$1.84M | |
| 2 | +$930K | |
| 3 | +$743K | |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$666K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$515K |
Top Sellers
| 1 | -$3.53M | |
| 2 | -$2.13M | |
| 3 | -$2.01M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$1.95M |
| 5 |
CA
CHI Advisors
New York
|
-$1.81M |